0001209191-15-040812.txt : 20150508 0001209191-15-040812.hdr.sgml : 20150508 20150508200023 ACCESSION NUMBER: 0001209191-15-040812 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150507 FILED AS OF DATE: 20150508 DATE AS OF CHANGE: 20150508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC CENTRAL INDEX KEY: 0001386858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611512713 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-745-7802 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scharschmidt Bruce Frederick CENTRAL INDEX KEY: 0001554402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35614 FILM NUMBER: 15848559 MAIL ADDRESS: STREET 1: C/O HYPERION THERAPEUTICS, INC. STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-07 1 0001386858 HYPERION THERAPEUTICS INC HPTX 0001554402 Scharschmidt Bruce Frederick C/O HYPERION THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005 0 1 0 0 SVP & Chief Medical Officer Common Stock 2015-05-07 4 U 0 97471 46.00 D 0 D Common Stock 2015-05-07 4 U 0 24448 46.00 D 0 I By The Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001 Common Stock 2015-05-07 4 D 0 18050 46.00 D 0 D Common Stock 2015-05-07 4 D 0 6975 46.00 D 0 D Stock Option (Right to Buy) 7.31 2015-05-07 4 D 0 25227 46.00 D 2022-04-15 Common Stock 25227 0 D Stock Option (Right to Buy) 24.26 2015-05-07 4 D 0 46000 46.00 D 2023-04-14 Common Stock 46000 0 D Stock Option (Right to Buy) 26.74 2015-05-07 4 D 0 32000 46.00 D 2024-03-10 Common Stock 32000 0 D Stock Option (Right to Buy) 25.97 2015-05-07 4 D 0 24000 46.00 D 2025-02-09 Common Stock 24000 0 D Stock Option (Right to Buy) 327.95 2015-05-07 4 D 0 191 0.00 D 2018-03-31 Common Stock 191 0 D Stock Option (Right to Buy) 327.95 2015-05-07 4 D 0 27 0.00 D 2018-04-21 Common Stock 27 0 D Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer. Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger"). Shares that are being acquired by Horizon in the Merger. Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger. Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger. /s/ Sally Brammell, Attorney-in-Fact 2015-05-08